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declined significantly with schistosome-specific IgE levels. 
Furthermore, sCD23 levels were negatively associated with 
skin sensitisation and IgE reactivity against HDM, but showed 
no relationship with total IgE.  Conclusion: The results are 
consistent with the suppression of parasite and allergen-
specific IgE levels by sCD23. Further mechanistic studies will 
determine the relevance of this potential regulatory mecha-
nism in the development of helminth-specific immune re-
sponses in atopic individuals. 
 Copyright © 2013 S. Karger AG, Basel 
 Introduction 
 Helminth infections, including schistosomiasis, and 
atopic disorders are characterised by high levels of IgE 
antibodies. Helminth-specific IgE responses are protec-
tive  [1–4] while high allergen-specific IgE levels are asso-
ciated with the clinical manifestations of allergy  [5–8] . In 
both cases, these IgE responses have been associated with 
increased CD23 expression  [9, 10] . sCD23 has been sug-
gested as a diagnostic marker in a range of diseases  [11] . 
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 Abstract 
 Background: Protective acquired immunity against hel-
minths and allergic sensitisation are both characterised by 
high IgE antibody levels. Levels of IgE antibodies are natu-
rally tightly regulated by several mechanisms including 
binding of the CD23 receptor. Following observations that 
helminth infections and allergic sensitisation may co-pres-
ent, the current study aims to investigate the relationship 
between the soluble CD23 (sCD23) receptor, parasite-speci-
fic IgE responses and allergic sensitisation in people ex-
posed to the helminth parasite  Schistosoma haematobium . 
 Methods: A cohort of 434 participants was recruited in two 
villages with different levels of  S. haematobium infection in 
Zimbabwe. Serum levels of the 25-kDa fragment of sCD23 
were related to levels of schistosome infection intensity, al-
lergen (house dust mite, HDM) and schistosome-specific IgE, 
total IgE and skin sensitisation to HDM.  Results: sCD23 levels 
rose significantly with schistosome infection intensity but 
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The CD23 (BLAST-2 or low affinity FcεRII) is a 45-kDa 
transmembrane low affinity IgE receptor found on the 
surface of naïve IgM+ IgD+ B cells  [12] . It also appears on 
the cell surface of macrophages, platelets, monocytes and 
eosinophils  [13] . It is characterised by three lectin do-
mains (heads) bound onto the membrane by a triple 
α-helical ‘tail’. The binding of IgE on membrane-bound 
CD23 is thought to inhibit the Cε gene transcription and 
IgE class switch, thus regulating IgE synthesis  [14, 15] . 
However, the tail region of the CD23 can be cleaved by 
endogenous proteases, in the presence of IL-4 and IL-13, 
resulting in release of soluble CD23 (sCD23) fragments 
to the serum  [14, 16] .
 CD23 is capable of both enhancing and inhibiting IgE 
production depending on the site of its cleavage. Cleavage 
of the membrane CD23 may occur at several proteolytic 
sites by metalloproteinases  [11] and the released frag-
ments may undergo further cleavage  [17] , resulting in 
monomeric and trimeric forms of sCD23. The trimers 
enhance survival and differentiation of IgE-committed B 
cells  [14] increasing IgE secretion by PBMCs, while the 
monomeric sCD23 (16 and 25 kDa) decrease IgE secre-
tion by PBMCs  [18–20] .
 An increase in circulating CD23+ B cells as well as sol-
uble CD23 (sCD23) has been associated with resistance 
to schistosome re-infection  [9] , while CD23+ B cells were 
higher in asthmatic compared to non-asthmatic children 
 [10] . In the mouse model, CD23 has been shown to have 
an inhibitory role in the development of allergic airway 
inflammation and airway hyperresponsiveness  [21] . To 
date, however, there are no studies describing the rela-
tionship between sCD23 levels and allergen-specific IgE 
levels concurrently with parasite-specific IgE levels. Un-
derstanding this relationship is important for determin-
ing mechanisms regulating IgE production both for the 
development of successful schistosome vaccines and suc-
cessful therapies for allergic diseases.
 We have previously shown that schistosome infec-
tion intensity is negatively associated with allergen-spe-
cific IgE but is positively associated with schistosome-
specific IgE responses  [22] . Nonetheless, the relation-
ship between sCD23 and schistosome infection 
intensity has not been widely studied. Therefore, the 
aim of the current study is to investigate whether sCD23 
is associated with schistosome infection intensity and 
how levels of sCD23 relate to atopy (skin prick test and 
allergen-specific IgE) and levels of schistosome-specific 
IgE  [22–24] . We focus on the monomeric 25-kDa 
sCD23 which is the most stable form of soluble CD23 
 [19] and hypothesise that the levels of sCD23 are nega-
tively associated with atopy (measured as allergen-spe-
cific IgE titres or size of the whirl in a skin prick test) in 
schistosome-infected populations. To differentiate the 
effects of current schistosome infection from the effect 
of previous infection on sCD23 levels, we used a com-
parative study design whereby sCD23 levels are com-
pared between two villages with different histories of 
schistosome infection. This study design has proved 
powerful in previous studies where the effects of host 
age on host immune responses  [25] can be separated 
from the effects of cumulative history of infection in 
lifelong residents of endemic areas  [22–24] .
 Materials and Methods 
 Study Design 
 The study was part of a larger programme investigating the im-
munoepidemiology, public health and control of schistosome in-
fection in Zimbabwean villages. This study was comparative, com-
paring levels of sCD23 in people resident in a high schistosome 
infection area to those residing in a low schistosome infection area 
(schistosome levels designated according to World Health Orga-
nization guidelines  [26] ). Differences in infection levels reflect dif-
ferences in infection transmission rates and thus different histories 
of infection amongst the villages  [23] . Residents of the high infec-
tion village accumulate infection more rapidly, acquiring higher 
infection intensities at a younger age and consequently develop 
acquired immunity against the parasites earlier than their counter-
parts in the low infection village  [23] . This study design was used 
to determine if these different histories of schistosome infection 
affected sCD23 levels.
 Study Population 
 A cohort of 434 participants was recruited from two villages, 
Magaya (high infection area (HIA), 17°63 ′ S, 31°91 ′ E) and Chi-
tate (low infection area (LIA), 17°67 ′ S, 31°88 ′ E) villages in the 
Mashonaland East Province of Zimbabwe where  S. haematobium 
is endemic. Magaya village is characterized by perennial rivers 
which lead to high transmission rates of schistosome parasites 
compared to Chitate village which is characterized by seasonal 
streams. In addition, households in Magaya are built along rivers, 
whereas in Chitate they are more dispersed and built further from 
the rivers as confirmed by GPS mapping of the area. Human con-
tact with water harboring cercariae, the infective stage of schisto-
somes, is frequent (as assessed by questionnaire studies) in this 
area due to insufficient safe water and sanitation facilities. The 
demographic composition of this cohort is detailed in  table 1 . All 
participants in this study were lifelong residents of the villages 
and had provided at least 2 stool and 2 urine specimens for the 
diagnosis of helminth infections. They were all egg-negative for 
geo-helminths and  S. mansoni , and had not previously received 
anti-helminthic treatment. No  Plasmodium parasites were de-
tected in the blood of the participants (this area is mesoendemic 
for malaria as detailed previously  [27] ). Thirty-three participants 
were HIV positive and the potential confounding effects of HIV 
infection  [9, 28] were accounted for in all statistical analyses.
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 Ethical Statement 
 Permission to conduct the study was obtained from the Provin-
cial Medical Director, while institutional and ethical approval was 
received from the University of Zimbabwe and the Medical Re-
search Council of Zimbabwe, respectively. All participants had the 
aims and procedures of the project explained, and written consent 
was obtained before enrolment into the study. For young children, 
written assent was obtained from parents/guardians. At the end of 
the study, all participants were offered treatment with the recom-
mended dose (40 mg/kg of body weight) of the anti-helminthic 
drug praziquantel.
 Immunological Assays 
 A maximum of 10 ml venous blood was collected from each 
participant into silicon-coated tubes without anticoagulant and se-
rum was extracted for enzyme-linked immunosorbent assays 
(ELISA) to quantify antibody levels.
 To determine the levels of sCD23, microtitre plates were coat-
ed overnight with 100 μl/well of capture antibody (anti-CD23, 
R&D Systems, cat. No. MAB1231) at 1 μg/ml in carbonate-bicar-
bonate buffer. Plates were washed and blocked with 2% BSA/
PBS/3%/tween20 for 2 h before the addition of samples. Serum 
samples were diluted at 1: 2 in 2% BSA/Tween 20 together with 
the standard (R&D Systems, cat. No. 123-FE). The secondary an-
tibody, biotinylated anti-human CD23, aa 150–321, R&D Sys-
tems, cat. No. BAF123, which detected the 25-kDA monomer of 
sCD23, was added at 0.2 μg/ml. 100 μl/well of streptavidin-horse-
radish peroxide (GE Healthcare) at 1: 6,000 were added after 
4 washes and plates were incubated for 2 h at 37  °  C. For the total 
IgE, plates were coated overnight with 5 μg/ml of the capture an-
tibody (anti-IgE, Dako), serum samples were diluted at 1: 50, and 
the secondary antibody (anti-human horseradish peroxide-con-
jugated IgE, Sigma) diluted at 1: 1,000. For allergen-specific IgE, 
plates were coated with 50 μl/well of affinity purified  Derma-
tophagoides pteronyssinus (house dust mite, Der p 1) allergen (In-
door Biotechnologies) at 5 μg/ml in carbonate-bicarbonate buf-
fer. Serum samples were diluted at 1: 10 and secondary antibody 
(anti-human horseradish peroxide-conjugated IgE, Sigma) at 1: 
 1,000. For anti-schistosome IgE responses, plates were coated 
with 5 μg/ml for cercarial antigen (CAP) and soluble worm anti-
gen (SWAP) and 10 μg/ml for soluble egg antigen (SEA); serum 
samples were diluted at 1: 20 and secondary antibody (anti-hu-
man horseradish peroxide-conjugated IgE, Sigma) at 1: 1,000 for 
SEA and CAP, and 1: 250 for SWAP.
 For all assays, the substrate (ABTS, Southern Biotech) was used 
for the colorimetric reaction and the optical density read at 405 nm. 
The antibody concentrations were extrapolated from a series of ti-
trations of standards (purchased from R&D Systems and NIBSC, 
respectively, for CD23 and IgE) which were run on each plate. The 
top standard concentration was 0.1 μg/ml for CD23 and 1,000 IU/
ml for total IgE. Antibody levels were expressed as ng/ml and IU/
ml, respectively, for CD23 and total IgE. Levels of Der p 1- and schis-
tosome-specific IgE responses were expressed as optical densities.
 Skin Prick Tests 
 As previously described  [22] , skin prick tests (SPT) were per-
formed using a preparation of the house dust mite (HDM) Derma-
tophagoides pteronyssinus , grass mix,  Alternaria tenius, and  Asper-
gillus fumigatus (all from Diagenics), and positive responders (skin 
prick result equal or higher than the positive control) classified as 
atopic individuals. This aspect of the study involved a subgroup of 
225 people (out of the 434) skin pricked (mean age: 21 years, range: 
6–86; mean infection intensity: 0.7 eggs/10 ml urine, range: 0–28). 
The majority of atopic individuals were sensitised to the HDM, 
consistent with previous reports  [29] . Therefore, the study focused 
on this allergen for both immunological assay and SPT to define 
atopy.
 Statistical Analyses 
 The study tested the effects of host factors on sCD23 levels as 
well as the relationship between sCD23 levels and skin prick reac-
tivity. The association between sCD23 levels and levels of other 
serological IgE (total IgE, allergen (Der p 1)-specific IgE and schis-
tosome-specific IgE) was also determined.
 Initially, infection intensity and prevalence were compared be-
tween the two villages using the general linear model (GLM) and 
χ 2   tests, respectively. In the GLM, infection intensity was the de-
pendent variable while sex, age, HIV status and village (HIA and 
LIA), were the independent categorical variables. Age was catego-
rised into three age-groups (6–10, 11–15 and  ≥ 16 years) reflecting 
epidemiological patterns of infection, i.e. ages 6–10, infection is 
rising; ages 11–15, infection is peaking and ages 16 and above, in-
fection is declining. Infection intensity was log 10 (x + 1) transformed 
to fulfil the assumptions of parametric tests conducted  [30] . All the 
statistical analyses were performed in PASW statistics 17 (formerly 
SPSS) and test statistics were considered significant at p < 0.05.
 To determine the host attributes related to levels of sCD23, an 
ANOVA was used with CD23 levels (square root transformed) as 
dependent variable and the host factors, host residential area (cat-
egorical, HIA/LIA), sex (categorical, male/female), age (categori-
cal, 6–10/11–15/ ≥ 16), HIV status (categorical, HIV negative/HIV 
positive) and infection status (categorical, infected/uninfected) or 
Table 1.  Demography and infection levels of the study populations
 Age groups, years
 6–10 11–15 ≥16
Magaya:
HIA
Number 103 86 34
Mean age, years 8.2 12.5 38.8
Sex ratio, M:F 50:53 37:49 14:20
Mean infectiona 17.2 39.1 2.4
Prevalence, %b 51.4 61.4 23.5
HIV-positive cases 4 4 6
Chitate: 
LIA
Number 77 51 83
Mean age, years 8.5 12.3 39
Sex ratio, M:F 38:39 24:27 11:72
Mean infectiona 0.76 1.03 0.22
Prevalence, % 9 11.8 4.8
HIV-positive cases 4 2 13
 The sample sizes (n), mean age, sex ratio and schistosome infec-
tion levels are shown, for each village, for the 3 age groups used in 
all analyses.
a Geometric mean of schistosome infection (egg count per 10 ml 
urine); b Prevalence of S. haematobium infection.
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infection intensity (continuous, log 10 (x + 1) transformed) as inde-
pendent variables. To calculate the F ratio in the ANOVA, sequen-
tial sums of squares were used and the independent variables were 
entered in the order they are listed above to allow for the potential 
confounding effects of all the other variables before testing the ef-
fects of schistosome infection intensity  [31] . β coefficients were 
used to determine the direction of the association.
 To establish whether atopic and nonatopic individuals (deter-
mined by SPT) exhibited differences in their antibody levels (total 
IgE and sCD23), a binary logistic regression analysis was per-
formed, using skin prick status as the dependent variable and sex, 
age, village, infection intensity, HIV status, and sCD23 or IgE lev-
els (square root transformed) as predictors.
 To determine whether sCD23 levels were related to levels of the 
serological levels of IgE (total IgE, Der p 1-specific IgE, schisto-
some-specific IgE), a MANOVA was conducted using each of the 
IgE variables (square root transformed) as the dependent variable 
and sCD23 (also square root transformed) as the independent 
variable after allowing for the potential effects of host residential 
area, sex, age, HIV status, and infection intensity with all indepen-
dent variables appropriately transformed or categorised as before.
 Results 
 Epidemiological Patterns of S. haematobium Infection 
 Infection intensity and prevalence were significantly 
higher in Magaya, the HIA, than in Chitate, the LIA (23.2 
vs. 0.6 eggs/10 ml; F 1, 428 = 63.295; p < 0.001 and 49.8 vs. 
8.06%; χ 2 = 90.743; p < 0.001, respectively). There was a 
significant age and village interaction (F 2, 426 = 10.466; p < 
0.001). As shown in  figure 1 a, infection intensity rose to a 
higher level and peaked at a younger age in the HIA com-
pared to the LIA, a pattern known as a ‘peak shift’  [23, 32] .
 Schistosome Infection Intensity Affects Levels of 
sCD23 
 There was a significant association between place of 
residence and sCD23 levels as shown in  table 2 . Post-hoc 
analyses showed that overall, levels of sCD23 were signifi-
cantly higher in the HIA compared to the LIA (t = 10.659, 
p < 0.001;  fig. 2 a). Comparison of total IgE levels between 
the two areas showed that levels of these antibodies were 
higher in the LIA (t = –2.08, p = 0.038;  fig. 2 b). After al-
lowing for the confounding effect of residential area, sex, 
age group and HIV status, ANOVA showed a significant 
effect of schistosome infection intensity on sCD23 levels, 
with sCD23 levels increasing with schistosome infection 
intensity. Schistosome infection status did not show a sig-
Table 2.  Determination of factors affecting levels of sCD23 using 
ANOVA
Factor d.f. F value p value
Village 422, 1 116 <0.001
Sex 422, 1 1.42 <0.234
Age group 422, 2 13 <0.001
HIV status 422, 1 0.07 <0.797
Schistosome infection intensity 422, 1 3.86 <0.05*
Village and age interaction 422, 2 1.76 <0.173
Village and infection intensity
interaction 422, 1 0.519
<
<0.471
Age and infection interaction 422, 2 0.017 <0.983
 * β coefficient = 0.028 (95% CI = 0.00012–0.057).
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 Fig. 1. Age profiles of the study villages. Geometric mean infection intensity ( a ) and sCD23 ( b ) are plotted against 
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terisks represent significant differences in each age group between the two villages at  * *  p < 0.01. 
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nificant relationship with sCD23 level (F 1, 427 = 1.908, p = 
0.168). Although sCD23 levels varied with host age, fol-
lowing the age-infection profile ( fig. 1 b), the interaction 
between age and residential village was not significant in-
dicating that the relationship between sCD23 levels and 
age did not depend on the residential area.
 Atopy Is Negatively Associated with Levels of sCD23 
 We initially established the relationship between SPT 
reactivity and levels of anti-Der  p  1 IgE. This analysis 
showed that SPT-positive people had significantly higher 
levels of the antibodies ( fig. 3 ). However, a binary logistic 
regression showed that atopic individuals (as determined 
by SPT), had significantly less sCD23 levels (B = –7.32, 
Wald = 7.663, p = 0.006;  fig. 4 a) but levels of total IgE did 
not differ between atopic and nonatopic individuals (B = 
0.018, Wald = 0.032, p = 0.858;  fig. 4 b).
 Dissociation between Total IgE and CD23 
 Analysis of the relationship between sCD23 levels and 
serological levels of IgE (total IgE, parasite-specific IgE 
and Der p 1-specific IgE) showed that parasite-specific 
IgE declined with increasing sCD23 levels as shown in 
 table 3 and  figure 5 a–c. This association was significant 
for all parasite-specific IgE responses, i.e. anti-CAP IgE, 
anti-SEA IgE and anti-SWAP IgE. In addition, levels of 
sCD23 were significantly negatively associated with levels 
of anti-Der p 1 IgE ( fig. 5 d), but showed no significant as-
sociation with total IgE levels as detailed in  table 3 and 
 figure 5 e.
 Discussion 
 Our study investigated the relationship between sero-
logical levels of the sCD23 receptor and IgE levels in peo-
ple exposed to schistosome infection. Overall, the study 
showed that sCD23 levels were negatively associated with 
antigen-specific IgE levels, and this was true for both 
schistosome-specific IgE levels and allergen-specific IgE. 
Interestingly, sCD23 levels showed no association with 
polyclonal IgE measured as total IgE. Of the different 
fragments of sCD23 released following cleavage of mem-
brane-bound sCD23, our assay detected the most stable 
form, the 25-kDa fragment.
 The data presented show that levels of sCD23 are sig-
nificantly higher in the high  S. haematobium infection 
area than the low infection area. Since the populations 
are similar in ethnicity and have comparable exposure 
background to other endemic infections such as malar-
ia ,  with exposure to schistosome infection being the only 
differing characteristic, this result suggested that the dif-
ference in schistosome infection may contribute to dif-
ferences in sCD23 levels. The lack of a peak shift in the 
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levels of sCD23 suggests that the differences in levels of 
sCD23 in residents of the different villages are due to 
current rather than cumulative history of infection. Fur-
thermore, analysis at the individual level demonstrat-
ed  a significant positive association between levels of 
sCD23 and current schistosome infection intensity re-
gardless of host village of residence. Interestingly, this 
association was lost if the level of the infection burden 
(infection intensity) was replaced by infection status, 
demonstrating that it was the burden of infection rather 
than infection status that drove the association with 
sCD23 levels.
 Similar to findings by other groups showing a negative 
association between helminth infection and atopy  [33–
36] , in this population schistosome infection intensity 
was negatively associated with atopy  [22] , so we related 
levels of sCD23 to skin prick reactivity. This revealed that 
SPT-positive individuals exhibit significantly lower levels 
of sCD23 than their SPT-negative counterparts. One po-
tential mechanism for this relationship would be inhibi-
tion of antigen-specific IgE synthesis through the cleav-
age of the CD23 molecule into small soluble monomer 
fragments with downregulatory effects on IgE synthesis 
 [16, 20] or inhibition of the trimerisation of these mono-
mer fragments  [37] .
 This result contrasted with findings in asthmatic pa-
tients where levels of sCD23 were significantly elevated 
in asthmatic compared to healthy controls  [38] . How-
ever, these authors also showed that sCD23 and mono-
cytes expressing CD23 were elevated in patients with in-
trinsic asthma (i.e. nonallergic), but that these, in con-
trast to allergic patients, did not translate into elevated 
levels of IgE, nor positive SPT. In the current study, SPT-
positive individuals had significantly higher levels of 
Der  p  1-specific IgE than their SPT-negative counter-
parts, suggesting an association between the levels of sen-
sitisation and the clinical manifestation of atopy in this 
population.
 The role for CD23 in suppressing atopy has been in-
vestigated in mouse experimental models. For instance, 
CD23 has been shown to have an inhibitory role in the 
development of allergic airway inflammation and airway 
hyperresponsiveness  [21] . Furthermore, CD23 has been 
implicated in the suppression of airway inflammation in 
mice chronically infected with the helminth parasite  He-
ligmosomoides polygyrus  [39] . A strain of mice naturally 
overexpressing IgE responses has also been shown to 
possess a variant CD23 present at low levels on B cells, 
which fail to trimerise and bind IgE  [37] . How these 
functions of bound CD23 molecules are related to the 
soluble forms remains to be ascertained. In addition, un-
like in humans, murine CD23 does not have the C-ter-
minal tail that binds CD21  [15] , so that these findings 
may not fully translate to the physiological function of 
sCD23 in humans.
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 Fig. 4. Comparison of sCD23 and total IgE 
levels in the study population. The mean of 
the square root-transformed concentra-
tions of sCD23 ( a ) and total IgE ( b ) are 
plotted for SPT-positive and -negative in-
dividuals. Bars represent standard errors of 
the means.  * *  p < 0.01 obtained from GLM 
analysis allowing for the effects of host sex, 
age, HIV status, village and infection inten-
sity. n.s. = Not significant (p > 0.05). 
Table 3.  Relationship between sCD23 and IgE levels
IgE F value p value β coefficient (95% CI)
CAP IgE 18.74 <0.001 –0.233 (–0.339 to –0.127)
SEA IgE 12.94 <0.001 –0.368 (–0.568 to –0.167)
WWH IgE 27.98 <0.001 –0.250 (–0.344 to –0.157)
Der p 1 IgE 11.58 <0.001 –0.093 (–0.147 to –0.039)
Total IgE 2.62 <0.107 – 1.23 (–0.264 to 2.713)
 MANOVA was conducted using each of the IgE variables 
(square root transformed) as the dependent variable and sCD23 
(also square root transformed) as the independent variable after 
allowing for the potential effects of host residential area, sex, 
age, HIV status, and infection intensity. Significant p values are 
highlighted in bold. The degrees of freedom for all tests were 
426, 1. 
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 In the current study, levels of polyclonal IgE were 
significantly higher in the LIA than the HIA, and were not 
significantly different between atopic and nonatopic 
groups. While there was no significant association between 
levels of sCD23 and total IgE, there were significant 
negative associations between sCD23 and the antigen-
specific IgE levels. In a study of bronchial asthmatic 
patients, sCD23 levels were found to be significantly 
positively correlated to the total IgE levels in both the 
asthmatic patients and non-asthmatic controls  [40] . One 
possible explanation for the differences in the two studies 
is that our study population was exposed to schistosome 
infection (which similar to previous reports  [41] was 
positively associated with levels of polyclonal IgE).
 Studies in  Leishmania chagasi have shown that para-
sites can down-modulate CD23 expression on human B 
cells and macrophage cell lines, in part by increasing the 
release of sCD23  [42] . The release of sCD23 was depen-
dent on the dose of the parasite, with increasing parasite 
doses resulting in increased levels of sCD23. This pat-
tern is consistent with the positive association we ob-
served between schistosome infection intensity and lev-
els of sCD23. Mechanistic studies of CD23/sCD23 dy-
namics in human cells exposed to schistosome antigens 
will determine if a similar phenomenon occurs in the 
helminth parasites.
 The negative association between the antigen-specific 
IgE levels and sCD23 is consistent with reports from oth-
er published work showing that monomeric sCD23 frag-
ments decrease IgE secretion by PBMCs  [18–20] . How-
ever, given that similar to other monomeric sCD23 frag-
ments, the 25-kDa monomer of sCD23 has pleiotropic 
effects on several cell types  [11, 43] , some of which are 
IgE-independent  [44] , the relationships observed here 
may not be directly causal but may be the result of sev-
eral pathways and interactions between different cell 
types. Therefore, detailed mechanistic and pathway stud-
ies are required to determine if these associations are 
causative or confounding. Overall the study raises an in-
teresting question as to why the sCD23 levels show a re-
lationship with schistosome-specific IgE and with aller-
gen-specific IgE and associated skin prick reactivity but 
not with polyclonal IgE. Understanding the regulation of 
antigen-specific IgE synthesis may contribute towards 
the development of safe helminth vaccines as well as im-
mune therapies for atopic diseases.
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Fig. 5. Relationship between sCD23 and IgE antibodies. Residuals (after allowing for age, sex, HIV status, village 
and infection intensity) of the square root-transformed concentrations of sCD23 are plotted against anti-
schistosome IgE responses (square root-transformed optical densities) ( a–c ), anti-Der p 1 IgE ( d ) and total IgE 
( e ). Significant results at p < 0.05 are highlighted in bold. 
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